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Abstract: In blood vessels, serotonin 5-HT2B receptors mainly mediate relaxation, 
although their activation by the selective agonist BW723C86 is known to exert 
contraction of aorta in deoxycorticosterone acetate (DOCA)-salt and N(omega)-nitro-
L-arginine (L-NAME) hypertensive rats [Russel et al., 2002; Banes et al., 2003] and in 
mice with type 2 diabetes [Nelson et al., 2012]. The unmasking effect on 
vasoconstriction can be caused by a shift in the balance of tyrosine phosphorylation 
in smooth muscle cells (SMC) due to oxidative stress induced inhibition of protein 
tyrosine phosphatases (PTP). We have demonstrated that BW723C86 which does not 
cause contraction of rat aorta and mesenteric artery rings, evoked a vasoconstrictor 
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effect in the presence of PTP inhibitors sodium orthovanadate (Na3VO4) or BVT948. 
BW723C86 induced a weak rise of [Ca2+]i in the SMC isolated from rat aorta; 
however, after pre-incubation with Na3VO4 the response to BW723C86 increased 
more than 5-fold. This effect was diminished by protein tyrosine kinase (PTK) 
inhibitor genistein, inhibitor of Src-family kinases PP2, inhibitor of NADPH-oxidase 
VAS2870 and completely suppressed by N-acetylcysteine and 5-HT2B receptor 
antagonist RS127445. Using fluorescent probe DCFH-DA we have shown that 
Na3VO4 induces oxidative stress in SMC. In the presence of Na3VO4 BW723C86 
considerably increased formation of reactive oxygen species while alone had no 
appreciable effect on DCFH oxidation. We suggest that oxidative stress causes 
inhibition of PTP and unmasking of 5-HT2B receptors functional activity. 
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Serotonin (5-hydroxytriptamine, 5-HT) plays an important role in regulating 
embryonic development, the functions of intestine, nervous, cardiovascular and 
other systems in adult organism. The action of serotonin is mediated by seven types 
of 5-HT receptors. In  blood vessels, 5-HT1B-, 5-HT1D-, 5-HT1F-, 5-HT2A-, 5-HT2B-, 
5-HT4- and 5-HT7-receptors have been identified [1,2]. 5-HT2A receptors play the 
main role in implementation of the vasoconstrictor effect of serotonin [3]. For several 
vessels contraction was demonstrated in response to 5-HT1B receptors stimulation 
[3]. 5-HT2B receptors are expressed in endothelial cells and vascular SMC [1,2,4]. 
Available data suggest that the 5-HT2B receptors mediate vasodilation through 
activation of NO synthesis [4]. On the other hand, an agonist of 5-HT2B receptors 
BW723C86 [5] causes constriction of de-endothelized renal arteries [6], suggesting a 
direct effect on the SMC. Normally BW723C86 has no effect on basal tone of the aorta 
and mesenteric arteries, however it induces vasoconstriction in DOCA-salt 
hypertensive rats [7] and L-NAME hypertensive rat [8] as well as in mice with type 2 
diabetes [9]. This suggests that 5-HT2B receptors operate as both vasodilators and 
vasoconstrictors, but normally their contractile effect is not manifested. The purpose 
of the present study was to find the conditions that lead to unmasking of 
vasoconstrictor effect of BW723C86. Since it is known that c-Src kinase plays an 
important role in the contractile action of serotonin [10], and protein tyrosine 
phosphatases (PTP) are inhibited by reactive oxygen species (ROS) which are 
increasingly produced in hypertension and diabetes [11], we assumed that an 
equilibrium shift in the tyrosine phosphatases/tyrosine kinases activities towards 
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tyrosine phosphorylation should cause unmasking of blood vessels contraction in 
response to BW723C86. To test this hypothesis, we used sodium orthovanadate 
(Na3VO4) and BVT948, which can induce an elevation of the intracellular 
concentration of ROS and promote inhibition of PTP through oxidation of SH-groups 
of cysteine [12,13], i.e. mimic processes that occur in oxidative stress. Calcium is 
playing a major role in vasoconstriction, so we studied whether inhibition of PTP 




2. Materials and methods 
2.1. Reagents. 
BW723C86 , RS127445, PP2, PP3, genistein from Tocris; DCFH-DA, Fura-2/AM 
from Molecular Probes; serotonin, angiotensin II, N-Acetyl-L-cysteine, TEMPOL (4-
hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl), VAS2870, Na3VO4, BVT948 from 
Sigma-Aldrich.  
2.2. Animals 
 Male Wistar rats weighting 250-300 g were anesthetized with 25%  urethane  (4 
ml/kg)  and decapitated. The thoracic part of aorta and superior mesenteric artery were then 
removed. All manipulations with the animals were performed in accordance with the National 
Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 
8023, revised 1978).  
2.3. Cell culture 
 Vascular SMC were derived from aorta of male Wistar rats in an explant method 
previously described in [14] and cultured in Dulbecco's Modified Eagle Medium (Sigma-
Aldrich) containing 10% fetal calf serum. 
2.4. Measurement of the mRNA expression of 5-HT2B, 5-HT2AR, 5-HT2C and 5-HT1B 
receptors 
 Total RNAs from rat aorta, mesenteric artery and rat aorta SMC was isolated using 
RNeasy MiniKit (QIAGEN). Reversed transcription was carried out using oligodT-primer. 
The levels of mRNA expression of 5-HT2B, 5-HT2A and 5- HT1B receptors were measured 
by real-time PCR. Elongation factor EF1a was used as the endogenous control. The following 
probes and primer pairs were used for amplification: for 5-HT2A receptors – FAM-
TCACCACAGCCGCTTCAACTCCAGA-BHQ1, sense – 
CGCTATGTCGCCATCCAGAAC, antisense –CAGATATGGTCCACACGGCAATG; for 
5-HTR2B receptor –  probe FAM-TGCTCTTTGGCTCACTGGCTGCCT-BHQ1, sense – 
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TGCTGACAAAGGAACGTTTTGG, antisense TTAGGCGTTGAGGTGGCTTG, for 5-
HTR2C receptors  probe  FAM-CGTTCTCATCGGGTCCTTCGTGGCA-BHQ1, sense  – 
GAAAGCAAAGTGTTCGTGAATAAC, antisense – TCCTCCTCGGTGTGACCTC; for 5-
HT1B receptors probe  FAM-AGCAGTCCAGCACCTCCTCCTCCGC-BHQ1, sense – 
CACCCTTCTTCTGGCGTCAAG, antisense – CCGTGGAGTAGACCGTGTAGAG, for 
EF1A – probe FAM-CTGTTCGTGACATGAGGCAGACAGTTG-BHQ1, sense – 
GACTACCCTCCACTTGGTCGTT, antisense – GCCTTCTTGTCCACGGCTT. 
2.5. Registration of aorta and mesenteric artery contraction 
Blood vessels, isolated from Wistar rats, were cleaned from connective tissue 
and cut into rings with a width of 2-3 mm. The rings were mounted on the holders in 
chambers filled with Krebs-Henseleit solution (37oC) perfused with 95% О2 / 5% СО2 
and extended with a force of 1 g for aorta and 0.75 g for mesentheric artery. 
Experiments were performed on a wire myograph (ADInstruments, Australia) using 
LabChart program for data acquisition and analysis.  
2.6. Measurement of free cytoplasmic calcium concentration in SMC  
Measurement of [Ca2+]i was performed on SMC from 2-6 passages grown in 
96-well plates. The cells were loaded with 2 µM Fura-2/AM dissolved with 0.02% 
Pluronic F-127 (Molecular Probes) during one hour incubation at 25◦С in a 
physiological salt solution (PSS) containing  NaCl (145 мМ), KCl (5 мМ), MgCl2 (1 
мМ), CaCl2 (1 мМ), Hepes (5 мМ), D-glucose (10 мМ), at pH 7.4. The fluorescence 
was measured in parallel from six wells at excitation wavelengths of 340 and 380 nm 
and emission wavelength of 505 nm using  a Synergy 4 Microplate Reader (BioTek, 
USA). The increments in [Ca2+]i are presented as ratios in the fluorescence at 340 and 
380 nm.  
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2.7. Detection of ROS in the smooth-muscle cells   
ROS generation in rat aorta SMC was assessed using 2',7'-
dichlorodihydrofluorescein diacetate (DCFH-DA) as a probe. The cells grown in 96-
well plates were incubated with 2 μM of DCFH-DA during one hour incubation at 
room temperature. Formation of ROS in the cells was determined by measuring the 
rate of DCFH oxidation into 2',7'-dichlorofluorescein (DCF). DCF fluorescence was 
measured at excitation wavelength of 485 ± 20 nm and with emitter bandpass of 527 ± 
15 nm. The rate of fluorescence rise was taken as an index ROS generation.   
2.8.Statistics  
Data are presented as mean±SEM of 6 to 18 measurements. Statistical 
significance was calculated using MedCalc statistical software according the one-way 
analysis of variance and Student-Neuman-Keuls test. Differences were considered to 





3.1. Assessment of 5-HT2 receptors mRNA in rat aorta and mesenteric arteries and in SMC 
isolated from rat aorta 
 mRNA of elongation factor EF1a was used as endogenous control and the contents 
of 5-HT2A, 5-HT2B, 5-HT2C and 5-HT1B receptor mRNA in  aorta and superior 
mesenteric artery of rat and in cultured SMC were calculated based on CT values. 
In both vessels and in SMC, the mRNA of 5-HT2A receptor is dominating (Fig.1). 
The content of 5-HT2B receptor mRNA relative to mRNA coding 5-HT2A receptor in 
aorta, mesenteric arteries and SMC was determined as 6.1±1.4, 5.4±0.6 and 36±11.1%, 
respectively. The relative level of 5-HT2C receptor mRNA in aorta and mesenteric 
artery was 0.22±0.14% and 0.24±0.03%, respectively, and only trace levels in SMC, 
0.012±0.002%. The relative content of 5-HT1B mRNA was 41.3±4.6% and 55.1±4.6% in 
the aorta and mesenteric artery and 0.74±0.19% in SMC. Thus, 5HT2B receptors are 
expressed in the rat aorta and mesenteric arteries, and in SMC  isolated from rat 
aorta; the level of their expression in the SMC is comparable with that of 5-HT2A 
receptors. 
3.2. Effects of BW723C86 on the contractility of rat aorta and mesenteric arteries in the 
presence of PTP inhibitors Na3VO4 or BVT948 
To investigate whether inhibition of PTP will unmask the vasoconstrictor 
effect of BW723C86 on isolated blood vessels, experiments were carried out on the 
rings of rat mesenteric arteries and aorta. There was no vasoconstrictive effect of 
BW723C86 at concentration range 0.1-100 M. However, added after PTP inhibitors 
Na3VO4 (500 M) or BVT948 (0.1 M), BW723C86 (1 M) induces contraction of 
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mesentheric artery rings (Fig. 2A). Na3VO4 or BVT948 themselves at concentrations 
500 and 0.1M respectively did not cause contraction. At higher concentrations, 1 
mM for Na3VO4 and 1 M for BVT948, each of them induces contraction of 
mesentheric artery ring without BW723C86. 
Effect of Na3VO4 on aorta at 500 µM was not consistent, causing either 
contraction or did not influence the aortic tone. Administration of 1 mM Na3VO4 to 
rat aortic rings resulted in their contraction, the force of which reached a maximum 
within 10 min. The initial contraction induced by 1 mM Na3VO4 was followed by 
slow relaxation. BW723C86 at 3 µM concentration added to the rings stabilized 
contraction and constant force was maintained at least for 25 min (Fig. 2B,C). 
3.3. Effects of orthovanadate and PTK inhibitors on [Ca2+]i elevation induced by BW723C86 
and 5-HT  in SMC isolated from rat aorta 
A rise of [Ca2+]i in vascular SMC is a trigger for vessel contraction. Therefore 
we studied whether inhibition of PTP activity will potentiate calcium signaling via 5-
HT2B receptors in SMC. Na3VO4 was chosen to evaluate how inhibition of PTP will 
affect signal transduction from 5-HT2B receptors. Another PTP inhibitor BVT948 was 
not used in these experiments because its fluorescence overlaps with Fura2 
fluorescence. Na3VO4 increased elevation of [Ca2+]i in response to BW723C86 by more 
than 5 times (Fig. 3A). The potentiating effect of Na3VO4 on the calcium signal was 
manifested equally over a concentration range of 100 to 500 µM. Antagonist of 5-
HT2B receptors RS127445 suppressed [Ca2+]i elevation in response to BW723C86  
(Fig. 3B). Serotonin is a more powerful inducer of [Ca2+]i elevation in rat aorta SMC 
compared to BW723C86 (Fig. 3A). Na3VO4 increased the serotonin-induced elevation 
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of [Ca2+]i by 31±11%. It has been shown previously that 5-HT2A receptors mediate 
elevation of [Ca2+]i in rat aortic SMC induced by serotonin [15]. In our experiments, 
RS127445 suppressed by more than 50+8% calcium response to 0.1 µM serotonin (Fig. 
3C). This indicates that 5-HT2B receptors along with 5-HT2A receptors mediate the 
action of serotonin on the SMC. 
The wide-spectrum PTK inhibitor genistein and Src kinase inhibitor PP2 
lowered the [Ca2+]i increase induced by BW723S86 added after Na3VO4 (Fig. 3B).  
Inactive analogue PP3 did not affect the calcium response. PP2 was also shown to 
inhibit the [Ca2+]i elevation due to 5-HT (Fig. 3C). Thus, Src kinase or other PTK 
belonging to the Src kinases family is involved in calcium signaling of 5-HT2B 
receptors.  
3.4. ROS formation under the influence of orthovanadate and BW723C86 in SMC  
The above data suggest that Na3VO4 augments the calcium response upon 
activation of 5-HT2B receptors through inhibition of PTP. It was previously shown 
that suppression of PTP activity is the result of oxidation of SH-groups [13]. It is 
known that orthovanadate can induce formation of H2O2 via superoxide anion as an 
intermediate product [16] and H2O2 inside the cell is able to oxidize SH-group in 
active center of PTP [17,18]. We therefore studied the effects of Na3VO4 and 
BW723S86 on accumulation of ROS in the SMC using a cell-permeable probe DCFH-
DA, which is cleaved in the cells to DCFH. DCFH can be oxidized by H2O2 and to a 
lesser degree by superoxide anion forming the fluorescent compound 2',7'-
dichlorofluorescein (DCF) [19]. The rate of fluorescence rise was taken as an index 
ROS generation. Without any additives there was a slow elevation in fluorescence, 
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representing spontaneous ROS formation (Fig. 4A). Administration of 300 µM 
Na3VO4 made the curve steeper that indicates  increased formation of intracellular 
ROS. Furthermore, addition of BW723C86 (10 µM) caused a sharp increase in the 
reaction rate (Fig. 4B), thus indicating activation of ROS. Without orthovanadate 
BW723C86 did not affect the rate of oxidation of DCFH in SMC.  
3.5.Suppression of  BW723C86-induced [Ca2+]i elevation by N-acetylcysteine and inhibitor of 
NADPH-oxidases VAS2870  
Since Na3VO4 effects are associated with the ROS formation, which can act as 
signaling molecules in vascular cells, we hypothesized that ROS are involved in 
potentiating calcium signaling in response to BW723C86. To test this hypothesis, we 
investigated the effects of antioxidant N-acetylcysteine (N-AcC) and tempol, a 
membrane-permeable radical scavenger and mimetic of superoxide dismutase 
(SOD), on BW723C86 induced elevation of [Ca2+]i in the presence of Na3VO4. 
Preincubation during 10 min with N-AcC almost completely reduced the growth of 
[Ca2+]i induced by BW723C86 (Fig. 4C). Tempol had no effect on the BW723C86-
induced calcium signaling. Since tempol catalytically removes superoxide anions 
though has no antioxidant activity against hydrogen peroxide [20]. we can eliminate 
the superoxide anion as a kind of ROS directly involved in the implementation of the 
potentiating effect of Na3VO4. To investigate the role of NADPH-oxidases in 
realization of the effect of BW723C86 on calcium signaling in SMC we used their 
selective inhibitor VAS2870 [21,22]. VAS2870 at a concentration of 10 M inhibited by 
79+4% the increase in [Ca2+]i that was induced by BW723C86 added after 200 M 





In this work we have demonstrated that silent vasoconstrictive 5-HT2B 
receptors are present in rat aorta and mesentheric artery and their functional activity 
is unmasked under the action of PTP inhibitors Na3VO4 and BVT948. Our data 
suggest that this occurs due to potentiating of calcium signaling via these receptors. 
Elevation of [Ca2+]i. in cultured SMC isolated from rat aorta in response to the agonist 
of 5-HT2B receptors BW723C86 is almost negligible and is manifested in the presence 
of Na3VO4. 5-HT induced increase in [Ca2+]i is potentiated by Na3VO4 and partially 
inhibited by 5-HT2B receptor antagonist RS127445. The latter shows that 5-HT-
induced elevation of [Ca2+]i in SMC is mediated both by 5-HT2A and 5-HT2B 
receptors. According to our knowledge, these is the first demostration of 5-HT2B 
receptors involvement in calcium signaling in vascular SMC. 
Earlier it was shown that orthovanadate increases the level of phosphorylation 
of proteins on tyrosine residues in SMC by inhibiting PTP [23,24]. We assume that 
potentiation of calcium signaling via 5-HT2B receptors and unmasking of aorta and 
mesentheric artery contraction in response to BW723C86 is caused by the shift in the 
balance of protein tyrosine phosphorylation towards phosphotyrosines. Shifting the 
balance of protein tyrosine phosphorylation to the initial position should attenuate 
[Ca2+]i rise induced by BW873C86 in the presence of Na3VO4. Indeed, PTK inhibitors 
genistein and PP2 decreased calcium response to BW723C86 in SMC, preincubated 
with Na3VO4. The effect of PP2 upon the increase of [Ca2+]i in the SMC caused by 
BW723C86 indicates that protein kinase belonging to the Src-kinases family 
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participates in calcium regulation in these cells through 5-HT2B receptors. Formely it 
was shown that Src-kinases are involved in signal transduction from angiotensin II 
receptors in SMC [25].   
Na3VO4 and BVT948 inhibit PTP as a result of oxidation of SH-group in the 
active center [12,13]. Our findings suggest that the effect of Na3VO4 on calcium 
metabolism in the SMC is triggered by oxidative stress, because the antioxidant N-
acetylcysteine almost completely abolishes the rise of [Ca2+]i caused by orthovanadate 
and BW723C86. Activation of the 5-HT2B receptors in the aorta SMC by BW723C86 
after exposure to Na3VO4 causes an additional substantial increase in the rate of 
oxidation of DCFH to DCF. We expect that the source of ROS is at least partially a 
NADPH oxidase since selective NOX inhibitor VAS2870 suppresses the effect of 
BW723C86 on [Ca2+]i in the SMC. The product of NOX-catalyzed reaction might be 
the superoxide anion produced in SMC by isoform NOX1, which is then converted to 
hydrogen peroxide, or H2O2 produced directly by the isoform NOX4 [26]. The 
superoxide dismutase mimetic tempol, which is known to catalytically remove 
superoxide anions [20], does not affect the calcium signaling. It follows that the 
superoxide anion itself does not directly potentiate BW723C86-induced [Ca2+]i 
elevation, but it might be  an intermediate from which hydrogen peroxide is 
produced. The formation of hydrogen peroxide in the SMC in response to 5-HT was 
previously shown with a specific probe HyPer [27]. Our data suggest that 5-HT2B 
receptors are involved in the implementation of this effect.  
The cause of vasoconstrictor action of 5-HT2B receptors at some diseases may 
be an elevation of their expression in vascular SMC [28], as well as increase in signal 
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transmission efficiency from these receptors. Our data apparently gives a clue to the 
understanding of the mechanism of the vasoconstrictive action of 5-HT2B receptors 
in L-NAME induced hypertension and DOCA-salt hypertensive rats [8,29] and in 
mouse model of type II diabetes mellitus [9]. Increased intracellular concentration of 
ROS is a well established pathogenic factor of hypertension and diabetes [11]. We 
suggest that manifestation of vasoconstrictive action of 5-HT2B receptors in these 
pathological states occurs due to oxidative stress evoked inhibition of PTP and 
potentiation of Ca-signaling in vascular SMC via 5-HT2B receptors. 
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Legends to figures 
Fig. 1. Relative contents of mRNA coding 5-HT-receptors  in rat aorta, rat 
mesenteric artery and SMCs from rat aorta.  The data are expressed as means ± SE 
(n=3). 
Figure 2. Effects of BW723C86 on the force of rat mesenteric artery (A) and aorta (B,C) 
rings contraction in the presence of Na3VO4 or BVT948. Each curve is a 
representative of 6 registrations on graph (A) and 4 registrations on graph (B). On (C) 
the average values of the force of aorta rings contraction induced by Na3VO4 25 
minutes after adding BW723C86 or vehicle are shown (n=4, *p<0.01). The mean value 
of the contraction force at the moment of BW723C86 or vehicle adding was 0.88+0.094 
g and taken as 100%. The mean values of the force of mesenteric artery ring 
contraction (A) in response to BW723C86 in the presence of Na3VO4 or BVT948 were 
0.65+0.078 and 0.46+0.044 g, respectively. On (B) adding of Na3VO4 is shown by white 
arrow and adding of BW723C86 or vehicle by black arrow. Grey curve depicts 
contraction in response to Na3VO4 in the absence of BW723C86 and black curve – in 
the presence of BW723C86. 
Figure 3. Potentiation of [Ca2+]i elevation in rat aorta SMCs in response to 
BW723C86 and 5-HT by Na3VO4 and its suppression by protein tyrosine kinase 
inhibitors and RS127445. (A) Kinetics of [Ca2+]i elevation in SMC in response to 
BW723C86 (A) or 5-HT (B) which were added after incubation during 3 min with 
Na3VO4 or vehicle. (B) Increments in [Ca2+]i in response to BW723C86 after incubation 
with vehicle, Na3VO4, Na3VO4 + PP3, Na3VO4 + PP2, or Na3VO4 + RS127445. (C) 
Increments in [Ca2+]i in response to 5-HT after incubation with vehicle, Na3VO4, PP3, 
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PP2 or RS127445. Effects of BW723C86 and serotonin without these agents were 
taken as 100%. The cells were incubated with PP3, PP2, genistein, RS127445 or 
vehicle for 8 min and then with or without Na3VO4 for 3 min. Concentration of 
Na3VO4 was 200 M, concentrations of BW723C86, PP3, PP2, genistein, RS127445 
were 10 M each. The average data of 6-9 independent measurements are expressed 
as mean ± SEM. On (B) *p<0.01 (Na3VO4 vs. vehicle; Na3VO4 vs. Na3VO4 + genistein or 
vs. Na3VO4 + RS12445; Na3VO4 + PP2 vs. Na3VO4 + PP3). On (C) **p<0.05 (Na3VO4  vs. 
vehicle and PP2 vs. PP3), *p<0.01 (RS127445 vs. vehicle). 
Figure 4. Generation of reactive oxygen species (ROS) in SMC in response to 
Na3VO4 and Na3VO4 with BW723C86 and influence of antioxidants and NADPH 
oxidase inhibitor VAS2870 on [Ca2+]i elevation induced by Na3VO4 and BW723C86. 
(A) Elevation of DCF fluorescence in SMC after adding of Na3VO4 (black arrow) and 
consequent adding of BW723C86 or vehicle (grey arrow). Black curve depicts effect 
of Na3VO4 with BW723C86. (B) The rates of DCF formation after adding of 
BW723C86 alone, Na3VO4 alone or Na3VO4 together with BW723C86. Spontaneous 
generation of ROS was taken as 100%. (C) Effects of tempol, N-acetyl cysteine (N-
AcC) and VAS2870 on [Ca2+]i elevation induced by Na3VO4 and BW723C86. 
Concentrations of N-AcC, VAS2870 and tempol were 2 mM, 10M  and 1 mM, 
concentrations of Na3VO4 was 300M in (A,B) and 200M in (C). Each value is an 
average of 6-18 measurements. The data are expressed as means ± SEM. * p<0.01 
(Na3VO4 vs. control and Na3VO4 + BW723C86 vs. Na3VO4 on B; N-AcC and VAS2870 
vs. control on C). 
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